JW Pharmaceutical (XKRX:001060) LT-Debt-to-Total-Asset : 0.08 (As of Mar. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. JW Pharmaceutical's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.08.

JW Pharmaceutical's long-term debt to total assets ratio increased from Mar. 2023 (0.04) to Mar. 2024 (0.08). It may suggest that JW Pharmaceutical is progressively becoming more dependent on debt to grow their business.

JW Pharmaceutical LT-Debt-to-Total-Asset Historical Data

The historical data trend for JW Pharmaceutical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical LT-Debt-to-Total-Asset Chart

JW Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.14

0.19

0.08

JW Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.04	0.08	0.13	0.08	0.08

JW Pharmaceutical LT-Debt-to-Total-Asset Calculation

JW Pharmaceutical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	52875.816	/	645038.796
	=	0.08

JW Pharmaceutical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	52419.333	/	657445.021
	=	0.08

JW Pharmaceutical (XKRX:001060) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

JW Pharmaceutical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical (XKRX:001060) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

001067:Korea 001065.PFD:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines